Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer
NCT05380336
·
clinicaltrials.gov ↗
COMPLETED
Status
40000
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Cancer
Sponsor
Nantes University Hospital